EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer

Rong Tang, Liquan Jin, Chen Chen, Yingna Liao, Dingru Li, Yangyi Li, Yueyue Chen, Yuan Liu, Qiong Du, Zeyin Rong, Jiaoshun Chen, Yubin Lei und 8 weitere

Cancer Cell · 2026

DOI: 10.1016/j.ccell.2026.05.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026. Verfasst von Rong Tang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China; Department of Oncology, Shanghai Medical College, …. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Education Commission, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional bulk-level transcriptomic sequencing cannot link cell type-specific gene expression to patient survival. In this study, we integrate single-nucleus RNA-seq and longitudinal data from 152 patients with pancreatic ductal adenocarcinoma (PDAC), profiling 1.2 million cells to construct a prognostic map connecting cell type-resolved gene expression with overall survival. Using a single-cell-resolved spatial transcriptomic platform, we further analyze 3.1 million cells and correlate their spatial distribution with therapeutic response. To empower the translational research community, we develop ctPANDA, an interactive platform offering cell-type-level prognostic insights. This atlas identifies PLOD2 as a promising target, with elevated expression predicting poorer outcomes across eight cell types. We have developed a proof-of-concept compound that can effectively degrade PLOD2 and inhibit PDAC progression in vivo. Collectively, this study advances the prognostic analysis from bulk-level to cell-type resolution, establishing a framework linking gene expression to clinical outcomes and providing actionable insights for target discovery and precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalTranscriptomeHumansAnimalsPrognosisGene Expression Regulation, NeoplasticGene Expression ProfilingSingle-Cell Gene Expression AnalysisMiceBiomarkers, TumorFemaleCell Line, TumorSpatial Transcriptomics

Stichwörter der Autor:innen

patient prognosisprecision treatmentsingle-nucleus transcriptometranslational medicine

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200030, China.
  • Shanghai Pancreatic Cancer Institute, Shanghai 200032, China; Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai 200032, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200030, China.
  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China; Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China.
  • Shanghai Pancreatic Cancer Institute, Shanghai 200032, China.
  • Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200030, China.

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Education Commission
  • Shanghai Municipal Health Commission
  • National Natural Science Foundation of China

Zitieren

APA

Tang, R., Jin, L., Chen, C., Liao, Y., Li, D., Li, Y., Chen, Y., Liu, Y., Du, Q., Rong, Z., Chen, J., Lei, Y., Wu, Z., Tan, Z., Wang, Y., Wang, H., Xu, J., Wang, W., Shi, S., & Yu, X. (2026). Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.05.012

Vancouver

Tang R, Jin L, Chen C, Liao Y, Li D, Li Y, et al. Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.05.012

BibTeX
@article{Tang2026,
  author = {Tang, Rong and Jin, Liquan and Chen, Chen and Liao, Yingna and Li, Dingru and Li, Yangyi and Chen, Yueyue and Liu, Yuan and Du, Qiong and Rong, Zeyin and Chen, Jiaoshun and Lei, Yubin and Wu, Zijian and Tan, Zhen and Wang, Yufeng and Wang, Haoyu and Xu, Jin and Wang, Wei and Shi, Si and Yu, Xianjun},
  title = {Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer},
  journal = {Cancer Cell},
  year = {2026},
  doi = {10.1016/j.ccell.2026.05.012}
}
Kostenlos starten →